P1289: COMPUTATIONAL SIMULATIONS SHED LIGHT ON THE 3D CONSEQUENCE OF SUPER-ENHANCER HIJACKING IN B CELL MALIGNANCIES

Lisa Russell , Daniel Kent , Aneta Mikulasova , Nefeli Karataraki
HemaSphere 6 1174 -1175

2022
OA-27 Single cell transcriptomics reveals the impact of tumor cell interactions with the bone marrow immune microenvironment in the progression of multiple myeloma

Parvathi Sudha , Mohammad Abu Zaid , Travis Johnson , Vivek Chopra
Clinical Lymphoma Myeloma and Leukemia 23 S16 -S17

2023
OA-32 The impact of genomics to identify novel immunotherapeutic targets in multiple myeloma

Enze Liu , Parvathi Sudha , Mohammad Abu Zaid , Travis Johnson
Clinical Lymphoma Myeloma and Leukemia 23 S19 -S20

2023
2
2016
SETD2 is a novel and druggable dependency in IMiD/CELMoD resistant multiple myeloma models

Sarah Anne Bird , Marco Licciardello , Yakinthi Chrisochoidou , James Smith
Cancer Research 83 ( 7_Supplement) 3879 -3879

2023
Building an NGS Workflow for FFPE Samples

Brian Walker , Elisa Izquierdo Delgado

Treatment to suppression of focal lesions on positron emission

Antje Hoering Barlogie , Gareth J Morgan , Sharmilan Thanendrarajan , Brian Walker

Coevolution in the chicken MHC: Polymorphic taps and shallow grooves

J Jacob , J Kaufman , L Shaw , F Johnston
In: Schat, KA, (ed.) CURRENT PROGRESS ON AVIAN IMMUNOLOGY RESEARCH, PROCEEDINGS. (pp. 162 - 162). AMER ASSOC AVIAN PATHOLOGISTS INC (2001)

2001
Deletion of CDKN2C drives the prognostic impact of deletion 1P in multiple myeloma

D Begum , S Ellis , A Price , C Smith
21st Congress of the European Hematology Association

2016
DYNAMIC EVOLUTION OF COPY NUMBER ABERRATIONS ACCOMPANIES DISEASE RELAPSE IN MULTIPLE MYELOMA

D Begum , S Ellis , C Smith , A Price
21st Congress of the European Hematology Association

2016
Acquired genetic events and NF1 mutations in advanced breast cancer

C Fribbens , I Garcia-Murillas , M Parton , A Nerurkar
American Association for Cancer Research

2019
Improving prognostic assignment in older age groups of multiple myeloma

EM Boyle , RR Litke , P Blaney , TC Ashby
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY 69 S198 -S198

2021
Identification of myeloma-associated miRNA and their prognostic value: a compendium from UK MRC myeloma IX trial

LUCA Agnelli , K Todoerti , P Wu , B Walker
Haematologica 97 ( Suppl. 2) S46 -S46

2012
Nivolumab for Treatment of Advanced, Refractory, High-Risk Multiple Myeloma

Sandra Susanibar , Maurizio Zangari , Carolina D. Schinke , Niels Weinhold
Blood 130 1858 -1858

4
2017
The molecular make up of smoldering myeloma highlights the evolutionary pathways leading to multiple myeloma.

Ola Landgren , Maurizio Zangari , Carolina Schinke , Francesco Maura
Nature Communications 12 ( 1) 293 -293

3
2021
PHF19 inhibition as a therapeutic target in multiple myeloma

Shmuel Yaccoby , Stephanie D. Byrum , Maurizio Zangari , Carolina D. Schinke
Current Research in Translational Medicine 69 ( 3) 103290 -103290

2021